HK Stock Market Move | ANTENGENE-B(06996) surged more than 8%, company founder and other management increased their holdings.

ANTENGENE-B (06996) rose more than 8%, as of the time of reporting, up 8.55% to HK$4.57, with a turnover of HK$187.563 million. On the news front, De Qi Pharmaceutical announced that the company's founder, executive director, CEO and chairman Mei Jianming purchased a total of 200,000 shares of the company through a controlled entity in the open market on March 23 and 24 at an average price of approximately US$0.512 (approximately HK$3.99) per share, representing approximately 0.029% of the total number of issued shares (excluding 202,500 shares of treasury stock). Following the purchase, Mei Jianming holds or is deemed to hold an interest in a total of 184 million shares, representing approximately 27.158% of the total number of issued shares. In addition, the company's executive director and CFO Long Zhengguo purchased a total of 502,500 shares in the open market on March 23 and 24 at an average price of approximately HK$4.006 per share, representing approximately 0.074% of the total number of issued shares. Following the purchase, Long Zhengguo holds or is deemed to hold an interest in a total of 4.4825 million shares, representing approximately 0.66% of the total number of issued shares. The company's vice president and company secretary Cao Yang purchased shares in the open market on March 23 and 24 for a total consideration of HK$1.042 million. The total consideration paid by Mei Jianming, Long Zhengguo, and Cao Yang for the purchases of shares in the open market amounts to HK$3.853 million.